The unaudited financial results for quarter ended June 30, 2025 has been approved by Implementation and Monitoring committee in its meeting held on December 27, 2025.
Awaiting price reaction for this filing.
Dharti Proteins Ltd, currently under Corporate Insolvency Resolution Process (CIRP) admitted by NCLT Ahmedabad on April 29, 2024, has approved its unaudited financial results for the quarter ended June 30, 2025, along with audited FY25 results and unaudited H1 FY26 results. The company reported total income of Rs. 2.29 lakhs in Q1 FY26 and Rs. 0.20 lakhs in Q2 FY26, with net losses of Rs. 4.60 lakhs and Rs. 0.42 lakhs respectively. The statutory auditor issued a qualified opinion citing serious concerns including going concern doubts (company has been inoperative for years with no trading/manufacturing activity), MSMED Act compliance issues, likely bad debts of Rs. 150.46 lakhs in loans and advances, and unpaid BSE listing fees. Net worth has turned negative at Rs. -3.75 lakhs as of June 30, 2025, against long-term borrowings of Rs. 205.72 lakhs.
This filing is highly negative for shareholders — the company is operationally inactive, under insolvency proceedings, posting consistent losses, and carries a qualified audit opinion with going concern doubts. The stock carries significant risk and shareholders face potential total loss under the ongoing CIRP process.